The European Public Health Alliance organises a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies. The next one is on the 8th of December. The topic is: “Will the EU be a wise ...
